Self-inoculation with Mycobacterium tuberculosis Weiszfeiler W-115.
After intracutaneous self-inoculation with 0.05 mg (wet weight) of Mycobacterium tuberculosis W-115 containing approximately 600 000 viable units, the local reaction was observed during a period of 9 weeks. No adverse effects or general reaction were observed. From the lesion the W-115 strain was recultivated. It was labelled W-115(78)ST vaccine strain and is used for further studies. On the basis of experiments on laboratory animals, monkeys, human new-borns and adults, the strain W-115 is considered as safe for antituberculous vaccination as the strains Mycobacterium bovis BCG and the attenuated "MP" strain of Mycobacterium microti OV 166.
D001500:BCG Vaccine / Q000009:adverse effects; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D014374:Tuberculin Test
D001500:BCG Vaccine